• By ICR Secretariat
  • Posted Monday, June 27, 2022

Roche Alzheimer's study fails in another setback to a long-tested hypothesis

https://www.biopharmadive.com/news/roche-alzheimers-crenezumab-colombia-study-failure/625640/

An experimental and closely followed drug for Alzheimer’s disease has failed a key clinical study, dealing yet another blow to the prevailing theory on how to treat a neurodegenerative illness that affects millions of people.